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1. Introduction
As an emerging research eld, the goal of Imaging Genomics is to study the integrative high-
throughput imaging (such as histopathological images in cancer research, MRI and PET im-
ages in brain study) and omics (such as SNP, DNA sequence, RNA expression, methylation,
epigenetic markers, proteomics, and metabolomics) data, which created new opportunities for
exploring relationships between genotypes, phenotypes, and clinical outcomes using quantita-
tive methods. Imaging Genomics research holds great promise for precision medicine to better
understand diseases, from genetic and genomic determinants to the complex interplay of phe-
notypic traits. The unprecedented scale and complexity of the Imaging Genomics data have
presented critical computational bottlenecks requiring new biomedical data science tools. The
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technological advance in this eld is urgently needed and has the potential to signicantly con-
tribute to multiple national health priority areas such as the BRAIN Initiative,1 the Precision
Medicine Initiative,2 and the BIGDATA Initiative.3
The objective of this Imaging Genomics Session at PSB 2018 is to encourage discussion on
fundamental concepts, novel methods and innovative applications. We hope that this session
will become a forum for researchers to exchange ideas, data, and software, in order to speed up
the development of innovative technologies for hypothesis testing and data-driven discovery
in Imaging Genomics.
2. Overview of Contributions
Our session includes seven accepted papers covering a variety of the subjects in the imaging
genomics eld. The papers address the imageing genomics research questions from genotype-
phenotype association studies of complex brain disorder and cancerous diseases to survival
analysis and disease characterization. The computational methods range from the convolu-
tional neural network methods to the low-rank based multi-task learning model. The large-
scale imaging and omics data from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
cohort, The Cancer Genome Atlas (TCGA), the Enhancing Neuroimaging Genetics through
Meta-Analysis (ENIGMA) Consortium, and The Cancer Imaging Archive (TCIA) have been
analyzed in the accepted papers.
Miller et al. analyzed the rare variants from whole-genome sequencing from the ADNI
cohort and identied several genes as signicantly associated with the imaging phenotype
using only synonymous variants that aected codon frequency. Their study showed that the
codon bias may play a role in Alzheimer's Disease and that it can be used to improve de-
tection power in rare variant association analysis. Huang et al. developed a deep survival
learning model to predict patients' survival outcomes by integrating the multi-dimensional
TCGA data. In order to take the advantage of both histopathological image information and
molecular proles from imaging-omics data, an integrative pipeline based on deep learning
model was created. The unsupervised training and supervised ne tuning processes are com-
bined to conduct survival prediction using a limited number of patient samples. Chidester et
al. introduced a Discriminative Bag-of-Nuclear-Words (DBoNW) method to predict genomic
markers using imaging features, which addresses the challenge of summarizing histopatholog-
ical images by representing nuclei with learned discriminative nuclear codewords. A reliable
patch-based nuclear segmentation scheme using convolutional neural networks was also devel-
oped to extract the nuclear features. Huo et al. proposed a new multi-task learning model to
analyze the associations between single nucleotide polymorphisms (SNPs) and quantitative
traits (imaging measures). The low-rank structure in the new multi-task learning model is
benecial to uncover the correlation between genetic variations and imaging phenotypes, such
that the candidate genes or loci which is relevant to the biological etiology of the disease can
be identied. Adhikari et al. developed a multi-site resting state functional MRI (rsfMRI)
analysis pipeline to allow research groups around the world to process rsfMRI scans in a
harmonized way, to extract consistent and quantitative measurements of connectivity and to
perform coordinated statistical tests. The ENIGMA-rsfMRI analysis pipeline was used to ver-
Pacific Symposium on Biocomputing 2018
305
ify and replicate the assertion that there is moderately strong genetic inuence on the resting
state signal. Han and Kamdar used a bi-directional convolutional recurrent neural network
model to predict the methylation state of the MGMT regulatory regions in Glioblastoma
Multiforme (GBM) patients via their brain MRI scans collected from TCIA combined with
methylation data from TCGA. Finally, Srivastava et al. studied the coherent \trans-omics"
features that characterize varied clinical cohorts across multiple sources of TCGA data for
more descriptive and robust disease characterization. The results showed that the histology
images outperformed molecular features while predicting cancer stages, transcriptomics held
superior discriminatory power for ER-Status and PAM50 subtypes, and there exist a few cases
where all data modalities exhibited comparable performance.
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